Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: J Thorac Oncol. 2012 Jun;7(6):1049–1052. doi: 10.1097/JTO.0b013e318250ed9d

Table 1.

Characteristics of all patients and germline cases*

Characteristic All patients
(N=11)
Germline cases
(N=5)
Age at
diagnosis
Median (Range) 56 (44–75) 56 (44–73)
Smoking
history
Never-smoker
Former/current smoker
6 (55%)
5 (45%)
4 (80%)
1 (20%)
First-degree
relative with
lung cancer
Present
Absent
3 (27%)
8 (73%)
2 (40%)
3 (60%)
Stage I
II
III
IV
2 (18%)
1 (9%)
0 (0%)
8 (73%)
1 (10%)
0 (0%)
0 (0%)
4 (80%)
Histology Adenocarcinoma 11 (100%) 5 (100%)
EGFR
sensitizing
mutation
Exon 19 deletion
Exon 21 L858R
Different mutations in different lesions
No sensitizing mutation
4 (36%)
6 (55%)
1 (9%)
0 (0%)
2 (40%)
2 (40%)
1 (10%)
0 (0%)
*

Two of these patients have been previously reported as part of a separate study6

One patient had multiple pulmonary nodules harboring different EGFR sensitizing mutations in addition to T790M, possibly representing multiple primary lung cancers rather than stage IV disease